(Q28245986)
Statements
Ocrelizumab: a step forward in the evolution of B-cell therapy (English)
0 references
July 2009
0 references
9
0 references
7
0 references
889-95
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference